Autism spectrum disorders and childhood-onset schizophrenia: Clinical and biological contributions to a relation revisited

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 48, Issue 1, 2009, Pages 10-18

  Rapoport, Judith ^a   Chavez, Alex ^a   Greenstein, Deanna ^a   Addington, Anjene ^a   Gogtay, Nitin ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Autism; Brain development; Childhood; Genetics; Schizophrenia

Indexed keywords

AUTISM; BRAIN DEVELOPMENT; BRAIN SIZE; CHILD; CHILD BEHAVIOR; CHILDHOOD DISEASE; COMORBIDITY; DEVELOPMENTAL DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PREDISPOSITION; ECHOLALIA; ERRATUM; GENE DELETION; GENE DUPLICATION; GENE LOCUS; GENETIC PREDISPOSITION; HUMAN; LANGUAGE DEVELOPMENT; MENTAL DISEASE; MISSENSE MUTATION; NEUROIMAGING; NONVERBAL COMMUNICATION; ONSET AGE; PARENT; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIZOPHRENIA; SIBLING; SOCIAL INTERACTION; VERBAL COMMUNICATION;

EID: 58249135361     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/CHI.0b013e31818b1c63     Document Type: Erratum

References (81)

1. American Psychiatric Association. Committee on Nomenclature and Statistics. Diagnostic and Statistical Manua of Mental Disorders. 2nd ed. Washington, DC: American Psychiatric Press; 1968.
2. American Psychiatric Association. American Psychiatric Association. Task Force on Nomenclature and Statistics. Quick Reference to the Diagnostic Criteria from DSM-III. Washington, DC: American Psychiatric Association; 1980.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Psychiatric Disorders. 3rd ed. Washington, DC: American Psychiatric Press; 1987.
4. Rapoport J, Ismond D. DSM-III Training Guide for Diagnosis of Childhood Disorders. New York: Brunner/Mazel; 1984.
5. Rutter M. The Emanuel Miller Memorial Lecture 1998. Autism: two-way interplay between research and clinical work. J Child Psychol Psychiatry. 1999;40:169-188.
6. Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism screening questionnaire: diagnostic validity. Br J Psychiatry. 1999;175:444-451.
7. Holstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet. 2001;2:943-955.
8. Folstein SE, Rutter ML. Autism: familial aggregation and genetic implications. J Autism Dev Disord. 1988;18:3-30.
9. Rutter M, Taylor E. Child and Adolescent Psychiatry. London: Blackwell: 2002.
10. Hollis C, Rapoport J. Child and adolescent schizophrenia. In: Weinberger D, Harrison P. eds. Schizophrenia. 3rd ed. London: Blackwell; 2008.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition-Text Revision. Washington. DC: American Psychiatric Association; 2000.
12. Demb HB, Noskin O. The use of the term multiple complex developmental disorder in a diagnostic clinic serving young children with developmental disabilities: a report of 15 cases. Ment Health Asp Dev Disabil. 2001;4:4960.
13. Sprong M, Becker HE, Schothorst PF et al. Pathways to psychosis: a comparison of the pervasive developmental disorder subtype multiple complex developmental disorder and the "at risk mental state." Schizophr Res. 2008;99:38-47.
14. de Bruin EL de Nijs PF, Verheij F, Hartman CA, Ferdinand RF. Multiple complex developmental disorder delineated from PDD-NOS. J Autism Dev Disord. 2007;37:1181-1191.
15. Kaufman J, Birmaher B, Brent D et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988.
16. Kolvin I, Ounsted C, Humphrey M, McNay A. Studies in the childhood psychoses. II. The phenomenology of childhood psychoses. Br J Psychiatry. 1971;1181:385-395.
17. Alaghband-Rad J, McKenna K, Gordon CT et al. Childhood-onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry. 1995;34:1273-1283.
18. Watkins JM, Asarnow RE, Tanguay PF. Symptom development in childhood onset schizophrenia. J Child Psychol Psychiatry. 1988;29:865-878.
19. Reaven J, Hepburn S, Ross RG. Use of ADOS and ADI-R in children with psychosis: importance of clinical judgement. Clin Child Psychol Psychiatry. 2008;13:81-84.
20. Weinberger D. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
21. Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402.
22. Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 1994;309:699-703.
23. Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 1994;309:699-703.
24. Isohanni M, Jones P, Kemppainen L et al. Childhood and adolescent predictors of schizophrenia in the Northern Finland 1966 birth cohorta descriptive life-span model. Eur Arch Psychiatry Clin Neurosci. 2000;250:311-319.
25. Cannon M, Caspi A, Moffitt TE et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002;59:449-456.
26. Impagnatiello F, Guidotti AR, Pesold C et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A. 1998;95:15718-15723.
27. Sporn AL, Addington AM, Gogtay N et al. Pervasive developmental disorder and childhood-onset schizophrenia: comorbid disorder or a phenotypic variant of a very early onset illness? Biol Psychiatry. 2004;55:989-994.
28. Krueger RF, Markon KE. Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Ann Rev Clin Psychol. 2006;2:111-133.
29. Buitelaar JK, van der Gaag RJ. Diagnostic rules for children with PDD-NOS and multiple complex developmental disorder. J Child Psychol Psychiatry. 1998;39:911-919.
30. van Engeland H, Van der Gaag RJ. MCDD in childhood: a precursor of schizophrenic spectrum disorders. Schizophr Res. 1994;11:197-207.
31. Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA. 2003;290:337-344.
32. Hazlett HC, Poe M, Gerig G et al. Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch Gen Psychiatry. 2005;62:1366-1376.
33. Williams DL, Minshew NJ. Understanding aurism and related disorders: what has imaging taught us? Neuroimaging Clin N Am. 2007;17:495-509.
34. Hazlett HC, Poe MD, Gerig G, Smith RG, Piven J. Cortical gray and white brain tissue volume in adolescents and adults with autism. Biol Psychiatry. 2006;59:1-6.
35. Mosconi M, Zwaigenbaum L, Piven J. Structural MRI in autism: findings and future directions. Clin Neurosci Res. 2006;6:135-144.
36. Thompson PM, Hayashi KM, Sowell E et al. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage. 2004;23:S2-S18.
37. Gogtay N, Giedd JN, Lusk E et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A. 2004;101:8174-8179.
38. Greenstein D, Lerch J, Shaw P et al. Childhood onset schizophrenia: cortical brain abnormalities as young adults. J Child Psychol Psychiatry. 2006;47:1003-1012.
39. Chagnon YC. Shared susceptibility region on chromosome 15 between autism and catatonia. Int Rev Neurobiol. 2006;72:165-178.
40. Di Cristo G. Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders. Clin Genet. 2007;72:1-8.
41. Fatemi SH. Reelin glycoprotein in autism and schizophrenia. Int Rev Neurobiol. 2005;71:179-187.
42. Gordon CT, Krasnewich D, White B, Lenane M, Rapoport JE. Brief report: translocation involving chromosomes 1 and 7 in a boy with childhood-onset schizophrenia. J Autism Dev Disord. 1994;24:537-545.
43. Vorstman JA, Morcus ME, Duijff SN et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry. 2006;45:1104-1113.
44. Weiss LA, Shen Y, Korn JM et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008;358:667-675.
45. Rapoport JE, Addingron AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10:434-449.
46. Lee JA, Lupski JR. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron. 2006;52:103-121.
47. Walsh T, McClellan J, McCarthy S et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways. Science. 2008;320:539-543.
48. Marshall CR, Noor A, Vincent JB et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82:477-488.
49. Kumar RA, KaraMohamed S, Sudi J et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet. 2008;17:628-638.
50. Kirov G, Gumus D, Chen W et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet. 2008;17:458-465.
51. Kim HG, Kishikawa S, Higgins AW et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet. 2008;82:199-207.
52. Zahir FR, Baross A, Delaney AD et al. A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha. J Med Genet. 2008;45:239-243.
53. Consortium TAGP. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet. 2007;39:319-328.
54. Feng J, Schroer R, Yan J et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett. 2006;409:10-13.
55. Cohen D, Lazar G, Couvert P et al. MECP2 mutation in a boy with language disorder and schizophrenia. Am J Psychiatry. 2002;159:148-149.
56. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet. 2001;69:428-433.
57. Kilpinen H, Ylisaukko-Oja T, Hernnah W et al. Association of DISC1 with autism and Asperger syndrome. Mol Psychiatry. 2008;13:187-196.
58. Friedman JI, Vrijenhoek T, Markx S et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry. 2008;13:261-266.
59. Alarcon M, Abrahams BS, Stone JL et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet. 2008;82:150-159.
60. Arking DE, Cutler DJ, Brune CW et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet. 2008;82:160-164.
61. Wedenoja J, Loukola A, Tuulio-Henriksson A et al. Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry. 2008;13:673-684.
62. Shifman S, Bhomra A, Smiley S et al. A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry. 2008;13:302-312.
63. Skaar DA, Shao Y, Haines JL et al. Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry. 2005;10:563-571.
64. Akbatian S, Huang HS. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev. 2006;52:293-304.
65. Addington AM, Gornick M, Duckworth J et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry. 2005;10:581-588.
66. Straub RE, Lipska BK, Egan MF et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry. 2007;12:854-869.
67. Yip AG, McKee AC, Green RC et al. APOE, vascular pathology, and the AD brain. Neurology. 2005;65:259-265.
68. Fatemi SH. The role of Reelin in pathology of autism. Mol Psychiatry. 2002;7:919-920.
69. Ogilvie CM, Moore J, Daker M, Palferman S, Docherty Z. Chromosome 22q11 deletions are not found in autistic patients identified using strict diagnostic criteria. IMGSAC. International Molecular Genetics Study of Autism Consortium. Am J Med Genet. 2000;96:15-17.
70. Sporn A, Addington A, Reiss AL et al. 22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry. 2004;9:225-226.
71. Ghebranious N, Giampietro PF, Wesbrook FP, Rezkalla SH. A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation. Am J Med Genet A. 2007;143:1462-1471.
72. Zoghbi H. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003;302:826-830.
73. Sebat J, Lakshmi B, Malhotra D et al. Strong association of de novo copy number mutations with autism. Science. 2007;316:445-449.
74. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry. 2006;11:1, 18-28.
75. Mollis C. Child and adolescent (juvenile onset) schizophrenia. A case control study of premorbid developmental impairments. Br J Psychiatry. 1995;166:489-495.
76. Stahlberg O, Soderstrom H, Rastam M, Gillberg C. Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Transm. 2004;111:891-902.
77. Mouridsen SE, Rich B, Isager T, Nedergaard NJ. Psychiatric disorders in the parents of individuals with infantile autism: a case-control study. Psychopathology. 2007;40:166-171.
78. Daniels JL, Forssen U, Hultman CM et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics. 2008;121:e1357-e1362.
79. Larsson HJ, Eaton WW, Madsen KM et al. Risk factors tor autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol. 2005;161:916-925.
80. Clegg J, Hollis C, Mawhood L, Rutter M. Developmental language disorders - a follow-up in later adult life. Cognitive, language and psychosocial outcomes. J Child Psychol Psychiatry. 2005;46:128-149.
81. Campbell M, Geller B, Small AM, Petti TA, Ferris SH. Minor physical anomalies in young psychotic children. Am J Psychiatry. 1978;135:573-575.